Dr. Reidy-Lagunes on Determining the Site of Unknown Primary in Metastatic NETs

Diane Reidy-Lagunes, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses an analysis looking at a practical method of determining the site of unknown primary in metastatic neuroendocrine tumors (NETs). This was presented by Jessica E. Maxwell, MD, MBA, from the University of Iowa, at a clinical science symposium at the 2014 NANETS Symposium.

More from NANETS: http://www.onclive.com/confere....nce-coverage/nanets-